Acadia Pharmaceuticals Inc (ACAD)

Income Tax Expense

-$259.12M

TTM · Period ending: · USD

ACAD logo

ACAD Income Tax Expense

Latest reported-$259.12M
ACAD TTM Income Tax ($7.28M → -$259.12M)
High-resolution chart · PNG

ACAD income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Acadia Pharmaceuticals Inc Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
-259,116,000
-260,544,000
-252,096,000
12,496,000
45,721,000
35,969,000
31,624,000
8,187,000
15,179,000
16,615,000
10,250,000
17,179,000
4,914,000
128,000
2,531,000
1,885,000
785,000
815,000
351,000
579,000
712,000
632,000
611,000
594,000
529,000
501,000
876,000
490,000
1,130,000
984,000
1,256,000
1,211,000
835,000
1,014,000
452,000
1,824,000
1,824,000
1,426,000
1,341,000
330,000
330,000
330,000
208,000
-184,000
-184,000
-184,000
-62,000
0
-16,000
-28,000
-40,000
-14,079,000
-14,063,000
-14,051,000
-14,039,000
-17,465,000
-17,465,000
-17,465,000
-17,465,000
-14,002,000
-14,002,000
-14,002,000
-14,002,000
-36,457,000
-36,457,000
-36,457,000
-36,457,000
-33,901,000
-33,901,000
-33,901,000
-33,901,000
-39,352,000
-39,351,000
-39,351,000
-39,351,000
-32,596,000
-33,873,000
-34,870,000
-35,503,000
-26,838,200
-26,068,600
431,271,600
642,693,600
648,043,600
756,442,000
298,900,000
88,160,200
110,265,550
5,896,700
7,168,200
7,277,100
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.